| Literature DB >> 26069127 |
Sung Uk Bae1, Byung Soh Min2, Nam Kyu Kim3.
Abstract
PURPOSE: By integrating intraoperative near infrared fluorescence imaging into a robotic system, surgeons can identify the vascular anatomy in real-time with the technical advantages of robotics that is useful for meticulous lymphovascular dissection. Herein, we report our initial experience of robotic low ligation of the inferior mesenteric artery (IMA) with real-time identification of the vascular system for rectal cancer using the Firefly technique.Entities:
Keywords: Robotics; blood supply; colectomy; colonic neoplasm; fluorescence; indocyanine green
Mesh:
Year: 2015 PMID: 26069127 PMCID: PMC4479832 DOI: 10.3349/ymj.2015.56.4.1028
Source DB: PubMed Journal: Yonsei Med J ISSN: 0513-5796 Impact factor: 2.759
Fig. 1Port placement for totally robotic rectal surgery using the single docking dual phase technique. (A) Port placement in the colonic stage. (B) Port placement in the pelvic stage.
Fig. 2Robotic-assisted lymph node dissection around the IMA with preservation of the LCA using the Firefly technique. (A) Dissection around the root of the IMA (white light image). (B) INIF image before visualizing the LCA by excited fluorescence. (C) INIF image of visualizing the LCA by excited fluorescence. (D)Skeletonization of the LCA and SRA from the IMA. (E) Low ligation of the IMA preserving the left colic branch. (F) Confirmation of blood flow of the LCA by INIF imaging. IMA, inferior mesenteric artery; LCA, left colic artery; INIF, intraoperative near infrared fluorescence; SRA, superior rectal artery.
Fig. 3Identification of the collateral artery near the IMV and pancreas. (A) Assessing the anatomical blood supply around the pancreas and IMV (white light image). (B) INIF imaging before visualizing the vascular flow by excited fluorescence. (C) INIF image of visualized arterial flow by excited fluorescence. (D)High ligation of the IMV with avoidance of injury to collateral vessels. IMV, inferior mesenteric vein; INIF, intraoperative near infrared fluorescence.
Patient Characteristics
| Patient number | 11 |
| Sex, n (%) | |
| Male | 6 (54) |
| Female | 5 (46) |
| Age (yrs), median (range) | 42 (31-55) |
| Body-mass index (kg/m2), median (range) | 22.9 (17.6-31.2) |
| ASA score, n (%) | |
| 1 | |
| 2 | |
| 3 | |
| Distance from anal verge (cm), median (range) | 4 (2-12) |
| Preoperative chemoradiation, n (%) | 7 (73) |
| Preoperative CEA (ng/mL), median (range) | 1 (1-52) |
| History of abdominal surgery, n (%) | 8 (13) |
ASA, American Society of Anesthesiologists; CEA, carcinoembryonic antigen.
Perioperative Outcomes
| Types of operations, n (%) | |
| LAR | 5 (45.5) |
| Ultra-LAR with colo-anal anastomosis | 5 (45.5) |
| Ultra-LAR with intersphincteric resection | 1 (9.0) |
| Total operation time (min), median (range) | 327 (226-490) |
| 1st docking time (min), median (range) | 5 (4-10) |
| 1st console time (min), median (range) | 88 (68-160) |
| 2nd docking time (min), median (range) | 3 (1-7) |
| 2nd console time (min), median (range) | 70 (40-100) |
| Low ligation of IMA, n (%) | 11 (100) |
| Time of low ligation, median (range) | 10 (6-20) |
| Time from ICG injection to clipping of SRA | 5 (2-8) |
| Blood loss (mL), median (range) | 200 (100-500) |
| Conversion, n (%) | 0 (0) |
| Protective diverting ileostomy, n (%) | 4 (36.4) |
| Days to 1st flatus (day), median (range) | 4 (2-5) |
| Days to 1st soft diet (day), median (range) | 4 (4-5) |
| Days to removal of the urinary catheter, median (range) | 2 (2-5) |
| Hospital stay, median (day) | 7 (5-9) |
| Morbidity within 30 days after surgery, n (%) | 3 (27) |
| Anal stricture | 1 (9) |
| Ileus | 1 (9) |
| Intraabdominal fluid collection | 1 (9) |
| Mortality, within 30 days after surgery, n (%) | 0 (0) |
LAR, low anterior resection; IMA, inferior mesenteric artery; ICG, indocyanine green; SRA, superior rectal artery.
Postoperative Pathologic Outcomes
| TNM stage, n (%) | |
| Stage 0 | 5 (45.5) |
| Stage I | 3 (27.3) |
| Stage II | 2 (18.2) |
| Stage III | 1 (9.1) |
| Histology, n (%) | |
| Well-differentiated | 1 (9.1) |
| Moderately-differentiated | 8 (72.7) |
| Mucinous | 1 (9.1) |
| Tumor size (cm), median (range) | 2 (0.5-3.0) |
| Total retrieved LNs, median (range) | 17 (9-29) |
| PRM (cm), median (range) | 14 (6-28) |
| DRM (cm), median (range) | 1 (0.5-4) |
| CRM positivity, n (%) | 1 (9) |
LNs, lymph nodes; PRM, proximal resection margin; DRM, distal resection margin; CRM, circumferential resection margin.